Help your patients say 'yes' to more moments.1-5

AJOVY® is the only anti-CGRP to offer the choice between quarterly and monthly dosing for the prevention of migraine, with the option to switch between the two1

Continue to Efficacy page of AJOVY

Significantly more migraine-free days vs placebo1-5

Continue to Flexibility page of AJOVY

Flexibility to help you meet your patients’ needs1,5

Felxibility of ajovy®
Continue to Safety page of AJOVY

A generally well-tolerated treatment choice1-5

safety profile of ajovy®
Continue to Clinical Trials page

AJOVY® was evaluated in four Phase III clinical trials (the HALO and FOCUS studies)2,3,5-7

Clinical trial designs
Continue to Efficacy page

Better quality of life with AJOVY® vs placebo8-10

Quality of life data for ajovy®
Continue to Administration page

Administered by the patient or a healthcare professional1


CGRP, calcitonin gene-related peptide.